Cosmo Pharmaceuticals N.V. | Income Statement
Fiscal year is January-December. All values CHF Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
69,377.20
96,645.40
64,713.60
73,739.50
74,650.90
75,759.90
Cost of Goods Sold (COGS) incl. D&A
23,584.40
26,154.80
21,469.40
21,633.40
24,410.70
25,467.70
Gross Income
45,792.80
70,490.50
43,244.20
52,106.10
50,240.20
50,292.20
SG&A Expense
31,129.20
43,579.20
49,069.90
26,063.40
61,424.20
70,505.40
EBIT
14,663.60
26,911.30
5,825.70
-
11,184.00
20,213.20
Unusual Expense
-
20,837.60
1,541.80
1,683.70
26.60
94.70
Non Operating Income/Expense
72,455.40
79,913.10
276,456.30
4,027.90
21,429.90
4,926.60
Interest Expense
343.40
333.90
285.10
164.60
126.60
1,206.50
Pretax Income
88,212.00
132,171.70
273,753.80
33,530.60
29,464.30
13,861.80
Income Tax
3,616.10
43,140.90
6,512.30
8,506.90
16.70
690.40
Equity in Affiliates
-
-
2,233.70
3,947.20
6,541.20
6,295.90
Consolidated Net Income
84,595.90
89,030.80
265,007.80
21,076.50
36,022.10
20,848.20
Net Income
84,595.90
89,029.60
265,008.80
21,076.50
36,022.10
20,790.50
Net Income After Extraordinaries
84,595.90
89,029.60
265,008.80
21,076.50
36,022.10
20,790.50
Net Income Available to Common
84,595.90
89,029.60
265,008.80
21,076.50
36,022.10
20,790.50
EPS (Basic)
5.92
6.21
18.79
1.49
2.43
1.39
Basic Shares Outstanding
14,298.80
14,334.40
14,103.00
14,103.50
14,809.80
15,005.40
EPS (Diluted)
5.91
6.10
18.40
1.27
2.43
1.39
Diluted Shares Outstanding
14,308.30
14,590.50
14,401.80
14,402.60
14,809.80
15,005.40
EBITDA
25,594.30
37,552.90
3,236.40
29,355.60
7,253.90
15,036.10
Non-Operating Interest Income
1,436.30
4,843.60
4,950.10
5,308.40
3,302.80
2,536.60
Minority Interest Expense
-
1.20
1.10
-
-
57.70
About Cosmo Pharmaceuticals
View Profile
